
Excited to share our new paper in @CMI_Journal.
We’ve identified a mechanism driving #GBM progression that also creates a targetable antigen from RCAN1 alternative splicing, and developed novel RCAN1-specific T cells with high efficacy. lnkd.in/eD9DrAcZ
English




